HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ekaterina Dadachova Selected Research

Radioimmunotherapy

12/2021Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models.
11/2020Mechanistic Insights into Synergy between Melanin-Targeting Radioimmunotherapy and Immunotherapy in Experimental Melanoma.
8/2020Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections.
1/2020Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody.
9/2019Evaluation of novel highly specific antibodies to cancer testis antigen Centrin-1 for radioimmunoimaging and radioimmunotherapy of pancreatic cancer.
7/2019Comparative Radioimmunotherapy of Experimental Melanoma with Novel Humanized Antibody to Melanin Labeled with 213Bismuth and 177Lutetium.
1/2019Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors.
1/2019Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors.
10/2018Evaluation of N-Succinimidyl S-Acetylthioacetate Ligand for Radiolabeling of Humanized Antibodies with 188Rhenium.
10/2018Radioimmunotherapy as a Novel Approach in HIV, Bacterial, and Fungal Infectious Diseases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ekaterina Dadachova Research Topics

Disease

54Neoplasms (Cancer)
12/2021 - 05/2002
18Communicable Diseases (Infectious Diseases)
12/2019 - 09/2003
17Infections
01/2022 - 05/2007
17Melanoma (Melanoma, Malignant)
11/2020 - 10/2004
8Breast Neoplasms (Breast Cancer)
03/2017 - 01/2003
7Experimental Melanoma
11/2020 - 04/2006
6Mycoses (Diseases, Fungus)
01/2022 - 02/2004
5Virus Diseases (Viral Diseases)
08/2020 - 09/2007
5Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2019 - 10/2007
4Osteosarcoma (Osteogenic Sarcoma)
12/2021 - 12/2016
4Pancreatic Neoplasms (Pancreatic Cancer)
09/2019 - 05/2013
3Cryptococcosis
01/2012 - 04/2009
3Anthrax
06/2010 - 10/2008
2Neurocognitive Disorders (Clerambault Syndrome)
02/2016 - 08/2014
2Body Weight (Weight, Body)
02/2014 - 12/2010
1Endocarditis
01/2022
1COVID-19
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Invasive Fungal Infections
08/2020
1Blastomycosis
01/2020
1Retinoblastoma (Glioblastoma, Retinal)
10/2019
1Testicular Neoplasms (Testicular Cancer)
09/2019
1Multiple Myeloma
01/2019
1Starvation
03/2017
1Viremia
01/2016
1Coinfection
08/2014
1Dementia (Dementias)
08/2014
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Inflammation (Inflammations)
01/2014
1Neoplasm Metastasis (Metastasis)
05/2013

Drug/Important Bio-Agent (IBA)

28Monoclonal AntibodiesIBA
01/2022 - 05/2002
25AntibodiesIBA
01/2022 - 09/2004
18Melanins (Melanin)IBA
11/2020 - 10/2004
16Radioisotopes (Radionuclides)IBA
11/2020 - 08/2005
12AntigensIBA
09/2019 - 09/2004
6Oncogene Proteins (Oncogene Protein)IBA
10/2019 - 10/2005
6Peptides (Polypeptides)IBA
05/2016 - 04/2006
5Therapeutic UsesIBA
01/2019 - 01/2004
5Viral AntigensIBA
02/2011 - 06/2007
4Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2007
4Pharmaceutical PreparationsIBA
01/2021 - 09/2004
4Complement System Proteins (Complement)IBA
10/2019 - 04/2013
4Immunoglobulin G (IgG)IBA
07/2019 - 09/2007
4Indicators and Reagents (Reagents)IBA
07/2019 - 09/2004
4Immunoglobulin M (IgM)IBA
02/2013 - 09/2007
3Insulin (Novolin)FDA Link
05/2021 - 12/2016
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 12/2009
2Bismuth-213IBA
08/2020 - 10/2018
2Cisplatin (Platino)FDA LinkGeneric
10/2019 - 02/2014
2Rhenium-188IBA
10/2018 - 01/2016
2Anti-Infective Agents (Microbicides)IBA
10/2018 - 11/2005
2DNA (Deoxyribonucleic Acid)IBA
10/2014 - 05/2012
26-hydrazinopyridine-3-carboxylic acidIBA
10/2011 - 11/2007
2Surface Antigens (Surface Antigen)IBA
01/2011 - 12/2006
2Amphotericin B (Amphotericin)FDA LinkGeneric
01/2011 - 08/2010
2benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
11/2010 - 02/2010
2Proteasome InhibitorsIBA
11/2010 - 02/2010
2alpha-MSHIBA
05/2010 - 12/2006
2Biological Warfare AgentsIBA
10/2008 - 09/2004
2Viral ProteinsIBA
10/2007 - 06/2007
2Immunoglobulin Fab FragmentsIBA
09/2007 - 12/2006
2sodium-iodide symporter (sodium iodide symporter)IBA
10/2005 - 03/2004
2SymportersIBA
10/2005 - 03/2004
2Glucose (Dextrose)FDA LinkGeneric
02/2005 - 01/2003
1Antimicrobial PeptidesIBA
01/2022
1RadiopharmaceuticalsIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2021
1venetoclaxIBA
01/2021
1lintuzumabIBA
01/2021
1Immune Checkpoint InhibitorsIBA
11/2020
1Chimeric Antigen ReceptorsIBA
09/2020
1beta-GlucansIBA
01/2020
1Growth Factor ReceptorsIBA
01/2019
1daratumumabIBA
01/2019
1Chelating AgentsIBA
10/2018
1N-hydroxysuccinimide S-acetylthioacetate (SATA)IBA
10/2018
1Phosphorus (Red Phosphorus)IBA
03/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017
1Mixed Function Oxygenases (Monooxygenases)IBA
03/2017
1EnzymesIBA
03/2017
1Epidermal Growth Factor (EGF)IBA
03/2017
1Biological ProductsIBA
12/2016
1MSH receptorIBA
05/2016
1Programmed Cell Death 1 ReceptorIBA
05/2016
1Lutetium-177IBA
01/2016
1Trypan BlueFDA Link
01/2016
1RNA (Ribonucleic Acid)IBA
10/2014
1PK 11195 (PK11195)IBA
08/2014
13- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA
08/2014
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
08/2014
1TNF-Related Apoptosis-Inducing LigandIBA
02/2014
1Capsules (Microcapsules)IBA
09/2013

Therapy/Procedure

42Radioimmunotherapy
12/2021 - 04/2004
41Therapeutics
05/2021 - 01/2003
3Immunotherapy
11/2020 - 05/2016
2Drug Therapy (Chemotherapy)
02/2013 - 04/2009
2Radiotherapy
12/2010 - 03/2004
1Catheters
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2020
1Highly Active Antiretroviral Therapy (HAART)
01/2014